From the beginning of the covid-19 pandemic, we have already tested approx. 2,500 patients as part of various research projects.

Despite the ongoing Covid-19 pandemic at the BRG facility, we are still active and with ongoing projects. We maintain constant contact with our patients who are open to participation in new research. In order to maintain appropriate prophylaxis and safety of the conducted projects we perform according to the highest standards, using instructions and procedures of the Ministry of Health, Sanitary-epidemiological station, WHO (World Health Organization) and EMA (European Medicines Agency).

We have already tested approximately 2,500 patients as part of various research projects. The safety of patients is supervised by qualified nurses, laboratory technicians, pharmacists and coordinators as well as recognized medical experts with many years of experience and knowledge. This confirm that our site is effective and efficient and able to provide rapid study start-up for trials research of various therapies even in challenging environment.

Go back

News

Happy Easter!

To all our employees, co-workers, clients and patients we would like to express our best wishes of joyful and peaceful Easter.

Read more …

Pediatrics Clinical Trials - conference

On 16th of April, 2019 we attended an interesting conference concerning clinical trials in pediatrics organised by GCPpl society.

Read more …

Personal Data Security in Clinical Trials

On 21st of March, 2019 our representatives attended workshops concerning personal data security in clinical trials.

Read more …

GCLP accreditation

We are proud to announce that on February 2019 we have received a GCLP certificate which confirms our high quality of services.

Read more …

Christmas wishes

To all our Sponsors, Vendors, Employees and Co-Workers we wish joy and happiness for the in-coming Christmas!

Read more …

About Us | Services | Our Site | Partners | Smoking Risk Study | Contact Us

Early Phase Clinical Trials

2024 © Bio Research Group. All rights reserved.

 

scroll to top ▲